Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
2 results
Filters applied: . Clear all
Page 1
RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer.
J Virol. 2022 Jul 13;96(13):e0056622. doi: 10.1128/jvi.00566-22. Epub 2022 Jun 15.
J Virol. 2022.
PMID: 35703545
Free PMC article.
Next generation L2-based HPV vaccines cross-protect against cutaneous papillomavirus infection and tumor development.
Ahmels M, Mariz FC, Braspenning-Wesch I, Stephan S, Huber B, Schmidt G, Cao R, Müller M, Kirnbauer R, Rösl F, Hasche D.
Ahmels M, et al.
Front Immunol. 2022 Oct 3;13:1010790. doi: 10.3389/fimmu.2022.1010790. eCollection 2022.
Front Immunol. 2022.
PMID: 36263027
Free PMC article.
Item in Clipboard
Cite
Cite